The future of clinical trials has never been in more need of innovation to keep advancing against
patient needs. Advances in technology, scientific discovery, data processing, and ways of engaging
patients are moving clinical research to the bleeding edge. And with R&D investments by
sponsors continuing to escalate, with one estimate putting expenditures at $233 billion in 2026
up from $186 billion in 2019, innovative thinking by leaders spanning the drug development
journey are needed to bring new breakthrough medicines to market to meet a multitude of
unmet therapeutic need.
Within this eBook, Parexel subject matter experts speak to some of the exciting trends that
are moving the industry toward the drug development of the future, including the next era
of precision medicine based on identifying tumor agnostic therapies, linking real world data
to connect the dots for improved therapeutic outcomes, using synthetic control arms to link
patients across multiple datasets using RWE, engaging patients in new ways to participate in
virtual or decentralized trials, and addressing the very specific needs of patients and caregivers
in the realm of rare diseases. The common theme throughout this publication is a dedication to
innovation and moving the needle of drug development and clinical trials forward and a future
where patients are at the heart of the process.